Winds of Open Innovation in Pharma
In a post on the lillycoi website Tom Krohn notes “the diversity of ways open innovation is manifested. While some seem to criticize that ‘everything is now open innovation’ I’ve come to appreciate the diversity. To me it isn’t about what it is called, but rather what it accomplishes. While diversity of approaches exist, it still seems to me that the focus of OI in pharma R&D remains in research, not development.”
Click here to read the full article.
